[12]Yoshida H,Hamano S,Senaldi G,et al.WSX-1 isrequired for the in itiation of Th1 responses and resistance to IL-27[J].major infection Immunity,2001,15:569-578.
[13]Pan HF,Tao JH,Ye DQ.Therapeutic potential of IL-27 in systemic lupus erythematosus[J].Expert Opin Ther Targets,2010,14(5):479-484.
[14]Villarino A,ibbert L,Liebennan L,et al.The IL-27R is required to suppress T cell hyper activity during infection[J].Immunity,2003,19(5):645-655.
[15]Sugiyama N,Nakashima H,Yoshimura T,et al.Amelioration of human lupus-like phenotypes in MRL/lprmice by overexpression of interleukin-27 receptor alpha (WSX-1)[J].Ann Rheum Dis,2008,67(10):1461-1467.
[16]Liu H,Rohowsky-Kochan C.Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1[J].J Interferon Cytokine Res,2011,31(5):459-469.
[17]Porcel JM.Advances in the diagnosis of tuberculous pleuritis[J].Ann Transl Med,2016,4(15):282.